The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer.
Li Z, Wang Y, Qiu J, Li Q, Yuan C, Zhang W, Wang D, Ye J, Jiang H, Yang J, Cheng J.
Li Z, et al. Among authors: wang y, wang d.
Oncotarget. 2013 Dec;4(12):2532-49. doi: 10.18632/oncotarget.1503.
Oncotarget. 2013.
PMID: 24345883
Free PMC article.